Acarix

medical devices

About

Acarix AB is a Swedish medical device company based in Malmö, founded in 2009. The company specializes in cardiac screening solutions aimed at the early detection of coronary artery disease (CAD). Acarix develops the CADScor® System, a non-invasive diagnostic device that utilizes advanced acoustics and AI-based processing to analyze coronary blood flow. This system allows for quick evaluations, typically completed in about 10 minutes, making it a valuable tool for primary care providers. The CADScor® System has received regulatory approvals, including in Canada, and is expanding its presence in the US market, which has significant growth potential. Acarix's products are available in various regions, including the Nordic countries, the UK, Germany, Switzerland, Austria, Mauritius, and the United States. The company aims to support general practitioners in performing early cardiac screenings, contributing to a more efficient and cost-effective diagnostic process for CAD. Acarix is publicly listed on Nasdaq First North Premier Growth Market in Sweden under the ticker ACARIX.

Technologies

MessageGears Outlook Microsoft Office 365 Google Tag Manager WordPress.org Mobile Friendly Nginx reCAPTCHA Vimeo Linkedin Marketing Solutions Google Font API

Keywords

acoustics stable chestpain coronary artery disease cad diagnostic aid healthcare clinical studies cad risk stratification blood flow analysis clinical research publications medical device patents medical devices regulatory compliance early diagnosis tool symptomatic patient assessment cardiology medical device innovation medical equipment and supplies manufacturing digital health patient-specific cad-score medical device b2b healthcare provider feedback medical technology healthcare technology government acoustic-based diagnostics point-of-care diagnostic coronary artery disease detection healthcare cost reduction

Location

12 Jungmansgatan, Malmoe, Skane County, Sweden, 211 11

Related Companies

Companies in the same industry